Personal information

Sarcoma, Cell Signalling, Cold Atmospheric Plasma, Osteosarcoma, Cell Invasion
Spain

Activities

Employment (5)

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA): Oviedo, Asturias, ES

2021-11-02 to present | PostDoc Researcher (Sarcomas y Terapias Experimentales)
Employment
Source: Self-asserted source
Tornin, J.

Universitat Politècnica de Catalunya: Barcelona, Catalunya, ES

2018-02-01 to 2021-11-02 | Postdoctoral Research Scientist (Biomaterials, Biomechanics & Tissue Engineering Research Group)
Employment
Source: Self-asserted source
Tornin, J.

Hospital Universitario Central de Asturias: Oviedo, Asturias, ES

2013-06 to 2017-06 | PhD Student (Head and Neck, and Sarcomas Cancer Research Unit)
Employment
Source: Self-asserted source
Tornin, J.

IUOPA: Oviedo, Asturias, ES

2012-06 to 2013-06 | PhD Student (Nutraceuticals Against Cancer)
Employment
Source: Self-asserted source
Tornin, J.

IUOPA: Oviedo, Asturias, ES

2012-06 to 2013-06 | PhD Student (Nutraceuticals Against Cancer)
Employment
Source: Self-asserted source
Tornin, J.

Education and qualifications (4)

Universitat Politècnica de Catalunya: Barcelona, Barcelona, ES

PostDoc Researcher (Biomaterials, Biomechanics and Tissue Engineering.)
Qualification
Source: Self-asserted source
Tornin, J.

Hospital Universitario Central de Asturias: Oviedo, Asturias, ES

2012 to 2017 | PhD (Head and Neck Cancer Research Unit)
Education
Source: Self-asserted source
Tornin, J.

IUOPA: Oviedo, Asturias, ES

2010 to 2011 | Master`'s Degree " Cancer Research" (Nutraceuticals Against Cancer)
Education
Source: Self-asserted source
Tornin, J.

Universidad de Oviedo: Oviedo, Asturias, ES

2005 to 2010 | Bachelor's Degree in Biology
Education
Source: Self-asserted source
Tornin, J.

Works (25)

A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

eBioMedicine
2024-04 | Journal article
Contributors: Verónica Rey; Juan Tornín; Juan Jose Alba-Linares; Cristina Robledo; Dzohara Murillo; Aida Rodríguez; Borja Gallego; Carmen Huergo; Cristina Viera; Alejandro Braña et al.
Source: check_circle
Crossref

Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells.

Free radical biology & medicine
2023-10-14 | Journal article
Contributors: Tornín J; Gallego B; Rey V; Murillo D; Huergo C; Rodríguez A; Canal C; Rodríguez R
Source: Self-asserted source
Tornin, J.

Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

Biomedicine & Pharmacotherapy
2023-06 | Journal article
Part of ISSN: 0753-3322
Contributors: Óscar Estupiñán; Verónica Rey; Juan Tornín; Dzohara Murillo; Borja Gallego; Carmen Huergo; Verónica Blanco-Lorenzo; M. Victoria González; Aida Rodríguez; Francisco Moris et al.
Source: Self-asserted source
Tornin, J.

Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma

Redox Biology
2023-06 | Journal article
Part of ISSN: 2213-2317
Contributors: Juan Tornín; Miguel Mateu-Sanz; Verónica Rey; Dzohara Murillo; Carmen Huergo; Borja Gallego; Aida Rodríguez; René Rodríguez; Cristina Canal
Source: Self-asserted source
Tornin, J.

Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer

Biomedicines
2023-01-14 | Journal article | Author
Part of ISSN: 2227-9059
Contributors: Dzohara Murillo; Carmen Huergo; Borja Gallego; Rene Rodriguez; Tornin, J.
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 2)‎

Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer

Free Radical Biology and Medicine
2022-08 | Journal article | Author
Part of ISSN: 0891-5849
Contributors: Miguel Mateu-Sanz; María-Pau Ginebra; Tornin, J.; Cristina Canal
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 2)‎

Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models

International Journal of Molecular Sciences
2022-06 | Journal article | Author
Contributors: Borja Gallego Martínez; Dzohara Murillo; Verónica Rey; Carmen Huergo; Óscar Estupiñán; Aida Rodríguez; Tornin, J.; Rene Rodriguez
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Proof of concept for the use of trained sniffer dogs to detect osteosarcoma.

Scientific reports
2022-04 | Journal article
Contributors: Ortal A; Rodríguez A; Solis-Hernández MP; de Prado M; Rey V; Tornín J; Estupiñán Ó; Gallego B; Murillo D; Huergo C et al.
Source: Self-asserted source
Tornin, J. via Europe PubMed Central

Mithramycin delivery systems to develop effective therapies in sarcomas

Journal of Nanobiotechnology
2021-12 | Journal article
Part of ISSN: 1477-3155
Source: Self-asserted source
Tornin, J.

Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures.

Nature protocols
2021-05-14 | Journal article
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 2)‎

Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy

Journal of Clinical Medicine
2021-02 | Journal article | Author
Contributors: Miguel Mateu Sanz; Tornin, J.; Maria-Pau Ginebra; Cristina Canal
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Osteosarcoma Tissue-Engineered Model Challenges Oxidative Stress Therapy Revealing Promoted Cancer Stem Cell Properties

Free Radical Biology and Medicine
2021-01 | Journal article
Source: Self-asserted source
Tornin, J.

Cold Plasma-Treated Ringer’s Saline: A Weapon to Target Osteosarcoma

Cancers
2020-01-17 | Journal article
Part of ISSN: 2072-6694
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 3)‎

The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

International Journal of Cancer
2019 | Journal article
EID:

2-s2.0-85060011052

Contributors: Estupiñan, O.; Santos, L.; Rodriguez, A.; Fernandez-Nevado, L.; Costales, P.; Perez-Escuredo, J.; Hermosilla, M.A.; Oro, P.; Rey, V.; Tornin, J. et al.
Source: Self-asserted source
Tornin, J. via Scopus - Elsevier

Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma

Scientific Reports
2019-12 | Journal article
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 2)‎

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042

Journal of Clinical Medicine
2019-08-02 | Journal article
Part of ISSN: 2077-0383
Source: Self-asserted source
Tornin, J.

New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth

Journal of Clinical Medicine
2019-04-04 | Journal article
Part of ISSN: 2077-0383
Source: Self-asserted source
Tornin, J.
grade
Preferred source (of 3)‎

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

Neoplasia (United States)
2018 | Journal article
EID:

2-s2.0-85035103728

Contributors: Tornin, J.; Hermida-Prado, F.; Padda, R.S.; Gonzalez, M.V.; Alvarez-Fernandez, C.; Rey, V.; Martinez-Cruzado, L.; Estupiñan, O.; Menendez, S.T.; Fernandez-Nevado, L. et al.
Source: Self-asserted source
Tornin, J. via Scopus - Elsevier

Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models

Neoplasia (United States)
2017 | Journal article
EID:

2-s2.0-85019703700

Contributors: Martinez-Cruzado, L.; Tornin, J.; Rodriguez, A.; Santos, L.; Allonca, E.; Fernandez-Garcia, M.T.; Astudillo, A.; Garcia-Pedrero, J.M.; Rodriguez, R.
Source: Self-asserted source
Tornin, J. via Scopus - Elsevier

Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.

2016 | Journal article
Contributors: Martinez-Cruzado L; Tornin J; Santos L; Rodriguez A; García-Castro J; Morís F; Rodriguez R
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.

2016 | Journal article
Contributors: Abarrategi A; Tornin J; Martinez-Cruzado L; Hamilton A; Martinez-Campos E; Rodrigo JP; González MV; Baldini N; Garcia-Castro J; Rodriguez R
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.

2016-04 | Journal article
Contributors: Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A et al.
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Bone microenvironment signals in osteosarcoma development.

2015-08 | Journal article
Contributors: Alfranca A; Martinez-Cruzado L; Tornin J; Abarrategi A; Amaral T; de Alava E; Menendez P; Garcia-Castro J; Rodriguez R
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.

2014-05 | Journal article
Contributors: Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F et al.
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation.

2013-10 | Journal article
Contributors: Rodriguez R; Tornin J; Suarez C; Astudillo A; Rubio R; Yauk C; Williams A; Rosu-Myles M; Funes JM; Boshoff C et al.
Source: Self-asserted source
Tornin, J. via Europe PubMed Central
grade
Preferred source (of 2)‎

Peer review (2 reviews for 2 publications/grants)

Review activity for Cancers. (1)
Review activity for PloS one. (1)